tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Tcr2 Therapeutics's activity chart (see below) currently has 37 price targets and 46 ratings on display.
Analysts average stock forecasts to be materialized ratio is 18.07% with an average time for these price targets to be met of 99.65 days.
Most recent stock forecast was given by from MIZUHO on 12-May-2023. First documented stock forecast 11-Mar-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-May-2023
$2.11
$0.63 (42.57%)
$1.72
3 years 4 months ago
(12-May-2023)
2/7 (28.57%)
$0.15 (7.65%)
86
Hold Since 27-Jul-2020
$2
$0.52 (35.14%)
$2
3 years 5 months 20 days ago
(23-Mar-2023)
0/3 (0%)
$0.58 (40.85%)
Buy Since 21-Sep-2021
$3
3 years 6 months 4 days ago
(08-Mar-2023)
0/2 (0%)
$1.4 (87.50%)
Hold Since 07-Mar-2023
3 years 6 months 5 days ago
(07-Mar-2023)
0/2 (0%)
$15.09 (385.93%)
Buy Since 11-Mar-2019
3 years 8 months 6 days ago
(06-Jan-2023)
0/4 (0%)
$28 (100.00%)
What is TCRR (Tcr2 Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on TCRR (Tcr2 Therapeutics)?
Which analyst has the most public recommendations on TCRR (Tcr2 Therapeutics)?
Which analyst is the currently most bullish on TCRR (Tcr2 Therapeutics)?
Which analyst is the currently most reserved on TCRR (Tcr2 Therapeutics)?
